Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected Patients
Datos Bibliográficos
| ID | 23356282 |
|---|---|
| Autores | Patricia García De Olalla (0000-0002-2293-3560, Universitat Autonòma de Barcelona, autor de correspondencia), Hernando Knobel (0000-0003-3186-6416, Hospital Del Mar), Alexia Carmona (Hospital Del Mar), Ana Guelar (0000-0001-6697-2652, Hospital Del Mar), José L López-Colomés (Hospital Del Mar), Joan A Caylà (0000-0003-3891-111X, Universitat Autonòma de Barcelona, autor de correspondencia) |
| Año | 2002 |
| Volumen | 30 |
| Número | 1 |
| Páginas | 105-110 |
| Fecha de publicación | 2002-05-01 |
| Peer Reviewed | Sí |
| Open Access | No |
| Tipo | ARTICLE |
| Revista | JAIDS Journal of Acquired Immune Deficiency Syndromes (JOURNAL) |
| Identificadores de la revista | ISSN: 1525-4135 • E-ISSN: 1944-7884 |
| Editorial | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/00042560-200205010-00014 |
| PMID | 12048370 |
| OpenAlex | W1993062623 |
| Idioma | EN |
| Citas recibidas | 78 |
| Referencias citadas | 30 |
OBJECTIVES: To assess the effect of antiretroviral therapy (ART) adherence on survival in HIV-infected patients. DESIGN: Cohort study at a single hospital in Barcelona, Spain. METHODS: Data on HIV-infected patients older than 18 years of age who began ART during the period 1990 to 1999 were analyzed. Patients were considered nonadherent if the total dose of antiretroviral drug was less than 90% of that prescribed. Adherence was assessed through self-report and hospital pharmacy appointments. Cox regression with time-dependent variables was used. RESULTS: A total of 1219 patients were included. The first ART was with monotherapy in 23.7% of cases, with two drugs in 30.5%, and with triple therapy in 45.8%. In multivariate analysis, the variables that presented significant differences with respect to mortality were clinical stage at the beginning of treatment (AIDS: relative hazard (RH) = 2.97; 95% confidence interval [CI]: 2.14-4.13), CD4 cell count (<200 cells/microL: RH = 5.89; CI: 3.44-10.10), type of treatment (monotherapy: RH = 9.76; CI: 4.56-20.90; bi-therapy: RH = 9.12; CI: 4.23-19.64), and adherence (nonadherence: RH = 3.87; CI: 1.77-8.46). CONCLUSIONS: The modifiable factors most strongly associated with survival were type of treatment and adherence. It would be desirable to accompany therapy with intervention strategies intended to improve adherence.
Antiretroviral therapy · Cohort · Cohort study · Combination therapy · Confidence interval · Hazard ratio · Human immunodeficiency virus (HIV) · Multivariate analysis · Pharmacotherapy · Proportional hazards model · Retrospective cohort study · Survival analysis · Viral load · HIV-related health complications and treatments · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions · Immunology · Internal Medicine · Medicine
Food Insecurity as a Barrier to Sustained Antiretroviral Therapy Adherence in Uganda
Unplanned antiretroviral treatment interruptions in southern Africa
Adesão em HIV/Aids
Validation and Abbreviation of an HIV Stigma Scale in an Adult Spanish-Speaking Population in Urban Peru
Comparison of Pharmacy-Based Measures of Adherence to Antiretroviral Therapy as Predictors of Virological Failure
Abuse and Resilience in Relation to Haart Medication Adherence and HIV Viral Load Among Women with HIV in the United States
Adherence to Haart Regimens
Less Than 95% Adherence to Nonnucleoside Reverse‐Transcriptase Inhibitor Therapy Can Lead to Viral Suppression
Barriers to HIV Medication Adherence
How am I going to live?”
The DREAM model's effectiveness in health promotion of Aids patients in Africa
Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users
Exploring the Communication of Social Support within Virtual Communities
Measuring Adherence to Antiretroviral Therapy in a Diverse Population Using a Visual Analogue Scale
Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and Aids in Botswana
Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda
Prevalence of DSM-IV-Defined Mood, Anxiety, and Substance Use Disorders in an HIV Clinic in the Southeastern United States
Multiple Validated Measures of Adherence Indicate High Levels of Adherence to Generic HIV Antiretroviral Therapy in a Resource-Limited Setting
Adherence to Highly Active Antiretroviral Therapy (Haart)
Self-Report Measures of Antiretroviral Therapy Adherence
Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users
Depression and HIV/Aids Treatment Nonadherence
Couple-focused support to improve HIV medication adherence
Adherence to antiretroviral therapy in adolescents living with HIV
Relationship with Health Care Provider and Adherence to HIV Medications
Stopping, starting, and sustaining HIV antiretroviral therapy
Relationship With Health Care Provider and Adherence to Hiv Medications
Hunger and Adherence to Antiretroviral Therapy
Living to suffer? Quality of life factors associated with adherence to antiretroviral therapy in Spanish HIV-infected children
HIV Testing Rates, Testing Locations, and Healthcare Utilization among Urban African-American Men
Comprehensive and Medically Appropriate Food Support Is Associated with Improved HIV and Diabetes Health
Viral suppression among persons living with HIV in Trinidad & Tobago
Monitoring Adherence to HIV Antiretroviral Therapy in Routine Clinical Practice
Effect of a Clinic-Wide Social Marketing Campaign to Improve Adherence to Antiretroviral Therapy for HIV Infection
Lack of Association between Retrospectively Collected Pharmacy Refill Data and Electronic Drug Monitoring of Antiretroviral Adherence
Substance Use Predictors of Poor Medication Adherence
Matching Social Support to Individual Needs
Depressive Symptoms, Lifestyle Structure, and ART Adherence Among HIV-Infected Individuals
Patient?Clinician Relationships and Treatment System Effects on HIV Medication Adherence
Personal Health Record Use and Its Association with Antiretroviral Adherence
Evaluation of the Single-Item Self-Rating Adherence Scale for Use in Routine Clinical Care of People Living with HIV
People with HIV in Haart-Era Russia
Primary Relationships, HIV Treatment Adherence, and Virologic Control
Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV
Unannounced Telephone-Based Pill Counts
Drug Use and Medication Adherence among HIV-1 Infected Individuals
Perinatal Depression and Anxiety in Women with and without Human Immunodeficiency Virus Infection
Improving adherence to antiretroviral treatment in Uganda with a low-resource facility-based intervention
Intentionality of medication non-adherence among individuals living with HIV/Aids in Hong Kong
Voices on adherence to ART in Ethiopia and Uganda
Impact of transitioning from HIV clinical trials to routine medical care on clinical outcomes and patient perceptions
Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment
Incidences and risk factors of first-line Haart discontinuation
Peer counselors' role in supporting patients' adherence to ART in Ethiopia and Uganda
Multidisciplinary care model for HIV improves treatment outcome
Reliability and validity of the Functional Assessment of Human Immunodeficiency Virus Infection (Fahi) in patients with drug and alcohol use disorders
Alcohol use and HIV disease management
The relationship between depression, anxiety and medication adherence among patients receiving antiretroviral treatment in South Africa
The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy
Treatment partners and adherence to Haart in Central Mozambique
Adherence in people living with HIV/Aids, mental illness, and chemical dependency
Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence
Antiretroviral therapy (ART) adherence and correlates to nonadherence among people on ART in Estonia
Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals
The cost of HIV medication adherence support interventions
Model of socio-cultural dimensions involved in adherence to antiretroviral therapy for HIV/Aids in public health care centers in Chile
The Case adherence index
An evaluation of the impact of a community-based adherence support programme on ART outcomes in selected government HIV treatment sites in South Africa
Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia
Adherence to antiretroviral therapy in a context of universal access, in Rio de Janeiro, Brazil
An empirical test of the Information, Motivation and Behavioral Skills model of antiretroviral therapy adherence
Sex differences in adherence to highly active antiretroviral therapy
Social factors affecting ART adherence in rural settings in Zambia
A qualitative study of persons who are 100% adherent to antiretroviral therapy
Intricacies and inter-relationships between HIV disclosure and Haart
Someone who is in this thing that I am suffering from”
Depression, adherence and attrition from care in HIV-infected adults receiving antiretroviral therapy
The Impact of Integrated HIV Care on Patient Health Outcomes
| Obras citantes distintas | 78 |
|---|---|
| Citas por año | 3,39 |
| Intervalo de citas | 2003 - 2022 (20) |
| Velocidad de citación | historical |
| Altamente citado | No |
| Tipos de cita | Neutras: 69 |